The administration of Pfizer-BioNTech Covid-19 vaccine to children under the age of 12 will begin in 2022, according to the health ministry.
The ministry said that currently, only the Pfizer-BioNTech Covid-19 vaccine is available for use on children below 12 and that it is awaiting regulatory approval from the European Union and the US.
“Pfizer is also expected to submit data related to the vaccine registration for use in children below 12 by the end of this year to the NPRA (National Pharmaceutical Regulatory Agency) for evaluation and approval,” the ministry said in a written reply posted on the Parliament website today.
The ministry was responding to a question from Wong Chen (PH-Subang) who wanted to know whether it intends to vaccinate children aged five to 12 years against Covid-19, and the implementation period for this.
According to the ministry, the government is currently in the process of procuring the Pfizer-BioNTech vaccine for the group as it has a different formulation than those used for the adult population, subject to approval from NPRA and the Drug Control Authority.
“A total of 5.9 million children are expected to be inoculated against Covid-19 involving an estimated 11.8 million doses of vaccine,” said the ministry.